Clinical Trial Update: Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy [Phase 1, Phase 2]

View source ↗

Summary

The document reports on a Phase 1/2 clinical trial evaluating rituximab for Graves' ophthalmopathy (dysthyroid ophthalmopathy / thyroid-related orbitopathy), wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy
• Thyroid-related Orbitopathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Silkiss, Rona Z., M.D., FACS | Conditions: Graves' Dysthyroid Ophthalmopathy, Thyroid Related Orbitopathy | Phase 1, Phase 2 | Status: COMPLETED